INDIANA UNIVERSITY HEALTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $21M
- Transactions
- 1,164
- Companies
- 40
- Average per transaction
- $18,025
Who reported the payments
| Cook Medical LLC | $7,931,755 |
| Stryker | $3,645,968 |
| Eli Lilly | $956,798 |
| Biomerieux Inc | $939,837 |
| Gilead | $899,889 |
| Merck | $855,215 |
| E.r. Squibb & Sons, L.L.C. | $660,123 |
| Medtronic | $594,078 |
| Takeda Pharmaceuticals U.S.A., Inc. | $583,066 |
| Corcept Therapeutics | $381,674 |
| Boston Scientific | $293,321 |
| Gyrus ACMI, Inc. | $265,130 |
| Angiodynamics, Inc. | $257,333 |
| Olympus Corporation Of The Americas | $243,000 |
| Janssen Research & Development, LLC | $179,084 |
| United Therapeutics Corporation | $170,577 |
| National Marrow Donor Program | $145,485 |
| Alnylam Pharmaceuticals Inc. | $142,026 |
| Lilly USA, LLC | $100,000 |
| Olympus America Inc. | $84,375 |
| Perspectum Diagnostics Ltd | $84,190 |
| Genentech, Inc. | $83,805 |
| Medline Industries LP | $83,622 |
| AstraZeneca | $83,117 |
| Roche Products Limited | $81,550 |
| Pfizer | $79,570 |
| Siemens Medical Solutions USA, Inc. | $77,044 |
| Medical Device Business Services, Inc. | $74,344 |
| Novartis | $61,267 |
| Ascendis Pharma Endocrinology Inc | $51,731 |
| Artivion, Inc. | $51,682 |
| Bolton Medical Inc | $51,668 |
| Alcresta Therapeutics, Inc. | $47,600 |
| Ipsen Innovation | $40,578 |
| Kls-martin L.p. | $40,311 |
| Abbott | $39,745 |
| Sumitomo Pharma America, Inc. | $37,957 |
| Medela AG | $33,750 |
| Soleno Therapeutics, Inc. | $32,009 |
| Avadel CNS Pharmaceuticals, LLC | $31,193 |